Robeauté
PrivateLast Round
Seed
Jan 14, 2025
Total Funding Raised
$33.75M
Company Overview
Robeauté is a French medtech company, founded in 2017, that is developing a new class of therapeutic microrobots for neurosurgery. These devices, approximately the size of a grain of rice, are designed to navigate through the brain's complex structures with minimal invasiveness to diagnose, treat, and monitor neurological conditions. The modular microrobots can be adapted for various clinical applications, including performing biopsies, delivering targeted drug therapies, implanting electrodes, and collecting real-time data. The company's mission is to overcome the limitations of current neurosurgical techniques, which are often highly invasive, and to bypass the blood-brain barrier that hinders many pharmaceutical treatments. Robeauté has secured over 50 patents for its technology and is currently in the preclinical trial phase, with human trials anticipated for 2026. The company has raised approximately $28 million in venture funding from investors including Plural, Cherry Ventures, and Kindred Ventures to advance its technology and pursue FDA approval.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Robeauté Comps
Public and private peers based on sector, stage, and business model.
Robeauté Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 14, 2025 | ||||
| Grant | Nov 13, 2023 | ||||
| Grant | Jun 2, 2020 | ||||
| Grant | Jul 4, 2019 |
Robeauté Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Think.Health | Seed |
| Région Île-de-France | Grant |
| European Innovation Council | Grant |
| LocalGlobe | Seed |
| Bpifrance | Grant |
| Kindred Ventures | Seed |
| EIT Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2026
Surgical micro-robotic platform successfully tested in living animals.
- Mar 1, 2026
Over 50 patents filed since 2017.
Robeauté Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Robeauté's valuation, stock price, and market status.
